BID and colorectal carcinoma: This study investigated the immunohistochemical expression patterns of key apoptotic regulators (BAD, BID, BCL2, MDM2, p53, and PUMA) and the proliferation marker Ki-67 in resectable stage II–III colorectal cancer (CRC) and evaluated their potential clinicopathological and prognostic significance.